Related Experiment Video
Updated: Dec 28, 2025

13:20
Detection of Bacteria Using Fluorogenic DNAzymes
Published on: May 28, 2012
19.6K
FRET-Based Aptasensor for the Selective and Sensitive Detection of Lysozyme
1Department of Chemistry, Virginia Commonwealth University, Richmond, VA 23284, USA.
Sensors (Basel, Switzerland)
|February 14, 2020
Summary
A novel aptasensor detects lysozyme using single-molecule fluorescence resonance energy transfer (smFRET). This sensitive and selective method offers a cost-effective way to detect disease biomarkers.
Area of Science:
- Biochemistry
- Molecular Biology
- Biotechnology
Background:
- Lysozyme is a key antimicrobial enzyme involved in immune modulation.
- Elevated lysozyme levels in body fluids can indicate diseases like Alzheimer's, Crohn's, and breast cancer.
- Existing lysozyme detection methods lack sensitivity, specificity, and quantitative capabilities.
Purpose of the Study:
- To develop a sensitive, selective, and quantitative detection method for lysozyme.
- To utilize aptamers for lysozyme detection via a single-molecule fluorescence resonance energy transfer (smFRET) approach.
- To create a cost-effective and regenerable aptasensor for protein biomarker detection.
Main Methods:
- Development of an aptasensor utilizing aptamers specific to lysozyme.
- Implementation of single-molecule fluorescence resonance energy transfer (smFRET) to detect lysozyme binding.
- Employing toehold mediated strand displacement (TMSD) for aptasensor regeneration.
Main Results:
- The aptasensor demonstrated high sensitivity, detecting lysozyme down to 2.3 picomoles (30 nM) with a dynamic range up to ~2 µM.
- The method showed minimal interference from similar biomolecules, ensuring specificity.
- The smFRET approach required significantly less aptasensor material compared to bulk methods and was cost-effective.
Conclusions:
- The developed smFRET-based aptasensor provides a sensitive, selective, and quantitative method for lysozyme detection.
- This aptasensing strategy is cost-effective, requires minimal reagents, and is regenerable.
- The platform is adaptable for detecting other protein biomarkers by simply changing the protein-specific aptamer.

